B2B2C MSK Kiio already operates as a B2B2C digital MSK care provider, partnering with sizable health insurers and employers. This suggests strong fit for expansion through additional insurer partnerships, large employer groups, and integration opportunities with benefits platforms to broaden adoption.

Cost-saving Outcomes Claims-based evidence indicates Kiio reduces pain, opioid use, and medical spend while improving function and productivity. Sales pitches can emphasize ROI to CFOs and benefit leaders, positioning Kiio as a cost-containment and value-add in MSK programs.

Growth through Health Plans Past and ongoing partnerships with WPS Health Insurance and Children’s Community Health Plan demonstrate receptivity from regional and Medicaid/Marketplace plans. Target similar risk-bearing entities and state-based programs to scale enrollment and coverage.

Executive Leadership Kiio has experienced leadership additions (CEO Lydia Zeller, Chief Growth Officer Afsana Akhter) indicating a growth-focused strategy. This can be highlighted to prospects as evidence of scalable operations, new market expansion, and dedicated go-to-market execution.

Technology & Accessibility A cloud-based, 24/7 digital solution accessible via mobile app with 1:1 coaching supports member engagement at scale. Prospects can be targeted on digital health platforms, employer wellness programs, and telehealth partnerships seeking scalable MSK care without in-person barriers.